Bowel-cleansing drugs to get black-box warning in U.S.

12/11/2008 | Washington Post (tiered subscription model), The

The FDA ordered a black-box warning for Salix Pharmaceuticals' Visicol and OsmoPrep to alert consumers about the risk of kidney injury from the oral sodium phosphate drugs. The warning is intended for patients older than 55, people who are dehydrated or have kidney disorders and individuals who use medicines that affect kidney function.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Economics & Reimbursement Manager - Transcatheter Heart Valve
Edwards Lifesciences
Irvine, CA
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA